Please login to the form below

Not currently logged in
Email:
Password:

voclosporin

This page shows the latest voclosporin news and features for those working in and with pharma, biotech and healthcare.

Lupus trial hailed as a success despite patient deaths

Lupus trial hailed as a success despite patient deaths

Lupus trial hailed as a success despite patient deaths. Phase IIb trial of Aurinia Pharmaceuticals’ voclosporin met its objective. ... The phase IIb trial of Aurinia Pharmaceuticals' voclosporin met its objective of improving complete remission rates

Latest news

  • Scratching the surface

    The ESSENCE and SPIRIT trials have been completed for Isotechnika's voclosporin, a calcineurin inhibitor and oral immunosuppressant. ... The likelihood of voclosporin gaining approval is 58 per cent, according to inThought analysts.

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Bayer veteran joins Aurinia as CEO Bayer veteran joins Aurinia as CEO

    Aurinia is well positioned to bring voclosporin forward as an important new treatment for lupus nephritis,” he said. ... companies. “ He is exceptionally qualified to help us build our voclosporin franchise and sharpen our execution.".

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Media

Four Health Media creates world class integrated media solutions with global reach, deep insight, innovative methods and a highly personal...

Latest intelligence

No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...

Infographics